Study On Qualty Control Of Production Process Of AIV (H9Subtype) Inactivated Vaccine Active Ingredient

Avian Influenza was firstly found in1878in Italy. It has broken out frequently through last century in Scotland, UK, Australia, U.S.A and Mexico. The economic damage met several billion dollars. Consequently, bad effects occurred on many businesses such as trade and traveling. Since the break-out of AIV in the year2004, Chinese government has carried on quite several effective measurements to release and control the AIV epidemic. According to the reports of China Biz, China has a large scale in raising poultry, raising quantity is9billion per year, and the total value of livestock husbandry holds40%of the total value of agriculture. In the year2000,50%of the income of the peasants was from livestock husbandry. Accompany with the development of Chinese livestock husbandry and the high speed of globalization of livestock products, it becomes more and more important to enhance the immunizations and integrated control of AIV. To produce effective vaccines of high quality is one of the key links for controlling and preventing AIV epidemic. The active ingredient acting as the main material for vaccine formulation, of which the quality determines the quality of the final products. In this essay, the producing procedure of the AIV active ingredient is described and discussed, meaning to guarantee and improve the quality of the final products of the AIV vaccines.